Noom Med Review 2026: App-driven users who want one all-inclusive bill and accept compounded-medication and billing caveats
Firsthand does not earn a commission from this product. We include it because rankings limited to affiliate partners can't be trusted.
Our verdict
Noom Med bundles clinician care, medication, and Noom's behavior-change app into quarterly-billed packages: the GLP-1Rx program is $129 to start, then $249/month all-inclusive for compounded semaglutide; a Microdose tier runs $79 to start, then $199/month; GLP-1Rx Plus with a compounded GLP-1/GIP (tirzepatide) is $299/month; and a branded-medication telehealth tier costs $99/month plus medication. All-inclusive pricing is genuinely simple, and the app coaching is Noom's strength. The concerns are equally concrete: Noom's core tiers still rely on compounded GLP-1s, which are not FDA-reviewed for safety, effectiveness, or quality now that the shortages permitting mass compounding were resolved in 2025. Noom's BBB file exceeds 1,000 complaints, with recurring reports of continued billing after cancellation. Its advertised results come from self-reported user data, not trials; the randomized STEP 1 trial attributes 14.9% mean weight loss at 68 weeks to semaglutide 2.4 mg. All prescriptions require clinician evaluation and eligibility screening.
Score breakdown
- Safety (30%)6.5/10
- Evidence (30%)6.0/10
- Cost & Value (20%)7.5/10
- Transparency (10%)6.5/10
- Support (10%)8.0/10
Scored per our review methodology.
Who it's for
Best for: App-driven users who want one all-inclusive bill and accept compounded-medication and billing caveats.
Pricing
GLP-1Rx: $129 to start, then $249/mo all-inclusive (compounded semaglutide); Microdose $199/mo; GLP-1Rx Plus $299/mo; branded-med telehealth tier $99/mo + medication cost
| Plan | Price | Notes |
|---|---|---|
| GLP-1Rx (compounded semaglutide) | $129 to start, then $249/mo (billed quarterly) | Clinical care, medication, and digital program included; no insurance required |
| Microdose GLP-1Rx / GLP-1Rx Plus | $79 start then $199/mo; Plus $149 start then $299/mo | Microdose caps at low semaglutide doses; Plus uses a compounded GLP-1/GIP (tirzepatide) |
| Telehealth for Branded Med | $39 to start, then $99/mo (quarterly) | Prescription and clinical care for branded GLP-1s; medication cost NOT included |
What the evidence says
- Randomized-trial evidence for semaglutide 2.4 mg (STEP 1) shows 14.9% mean weight loss at 68 weeks; Noom's advertised outcomes are self-reported user data, not trial results. (STEP 1 trial (NEJM 2021): Once-Weekly Semaglutide in Adults with Overweight or Obesity)
- 2025 clinical guidance details what providers must consider with compounded semaglutide, including quality variability and the narrowed legal basis for compounding after shortage resolution. (Am J Manag Care 2025: Navigating compounded semaglutide)
- Case reports to a poison control center documented 10-fold administration errors with compounded semaglutide, a risk absent from manufactured prefilled pens. (J Am Pharm Assoc case series: compounded semaglutide administration errors)
Pros & cons
Pros
- All-inclusive pricing: clinical care, medication, and the Noom app in one quarterly-billed fee
- Strong behavioral program with psychology-based coaching alongside medication
- Multiple tiers, including a lower-cost microdose option and a $99/month branded-medication pathway
- FSA/HSA-eligible plans and no insurance required
Cons & red flags
- Red flag: core GLP-1Rx tiers are built on compounded semaglutide and tirzepatide even after the FDA declared the shortages resolved in 2025, and Noom's own disclosure notes compounded drugs are not FDA-reviewed for safety, efficacy, or quality
- Red flag: over 1,000 BBB complaints, with a recurring pattern of continued charges after users attempt to cancel
- Marketing leans on self-reported user outcomes (e.g., 'lose up to 33 pounds in 6 months' from top-quartile users) rather than clinical trials
- Quarterly billing means a cancellation misstep can cost a full three-month cycle
- Microdosing GLP-1s below trial-tested doses lacks published efficacy evidence
How it compares
Noom Med scores 6.7/10 in our weight loss evaluation. See where it lands in the full ranking: Best Weight-Loss Supplements of 2026.
- Ro (Ro Body) review — 8.4/10, cash-pay patients who want branded glp-1s at manufacturer direct rates with insurance-coordination help
- WeightWatchers Clinic (WW Med+) review — 8.3/10, insured patients who want hands-on prior-authorization help plus a structured behavioral program
Frequently asked questions
How much is Noom Med per month?
Noom's GLP-1Rx program costs $129 to start and then $249/month billed quarterly, all-inclusive of compounded semaglutide, clinical care, and the app. The Microdose tier is $199/month, GLP-1Rx Plus is $299/month, and a branded-medication tier is $99/month plus the medication's own cost.
Is Noom GLP-1 compounded or brand name?
Both exist, but the flagship tiers ship compounded semaglutide or a compounded GLP-1/GIP. Compounded versions are made in FDA-registered facilities but are not FDA-reviewed for safety, effectiveness, or quality. A separate $99/month tier arranges prescriptions for branded medications instead.
Is it hard to cancel Noom Med?
Noom's BBB profile exceeds 1,000 complaints, and a recurring theme is being billed after attempting to cancel, including quarterly renewals landing on or after the cancellation date. Cancel well before your renewal date and keep written confirmation.
Do you need insurance for Noom Med?
No. Noom Med plans are cash-pay and FSA/HSA-eligible; the compounded tiers include medication in the price, so insurance is not part of the flow.
Get evidence-based health picks in your inbox — no hype.
Join The Firsthand Brief for a weekly, research-first read.
We never sell your email. Unsubscribe anytime. See our privacy policy.